NEW DELHI (Reuters) – Nepal on Friday gave emergency authorisation to India’s COVID-19 vaccine COVAXIN, developed by Bharat Biotech and a state-run research institute, Nepal’s drug regulator said in a statement.
“Conditional permission has been granted for emergency use authorisation,” the Department of Drug Administration said.
(Reporting by Gopal Sharma; editing by John Stonestreet)
